WallStSmart
HKPD

Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares

NASDAQ: HKPD · HEALTHCARE · MEDICAL DISTRIBUTION

$0.56
-2.06% today

Updated 2026-06-05

Market cap
$9.28M
P/E ratio
P/S ratio
0.57x
EPS (TTM)
$-0.06
Dividend yield
52W range
$0 – $2
Volume
0.2M

Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item202320242025
Total assets$3.41M$8.67M$9.42M
Cash & equivalents$524613.00$619575.00$748721.00
Current assets$2.75M$7.80M$8.73M
Total liabilities$2.82M$4.41M$4.43M
Current liabilities$2.55M$3.18M$2.92M
Long-term debt$116862.00$1.12M$1.50M
Shareholder equity$585242.00$4.25M$4.99M
Retained earnings$201391.00$1.53M$1.50M
Accounts receivable$1.70M$3.72M$4.71M
Inventory$190887.00$933299.00$559982.00
Goodwill

Frequently asked questions

What is Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares's revenue?

Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares's trailing twelve-month revenue is $16.36M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is HKPD?

In its most recent fiscal year, HKPD ran a gross margin of 11.89%, an operating margin of 0.65%, and a net margin of -0.13%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does HKPD generate?

HKPD produced $414226.00 in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is HKPD's balance sheet healthy?

HKPD holds $748721.00 in cash and equivalents against $1.50M in long-term debt, on $4.99M of shareholder equity. That debt is best read against the cash flow the business throws off each year.